Page 157 - 2022 Ranger Medic Handbook
P. 157
ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE (MAALOX)
Class: Antacid
Action: Neutralizes gastric acid, increases gastric pH
Dose: Oral liquid 200mg/200mg/5mL; 10–20mL q6hr prn; max: 80mL/24hr
Indications: Relief of indigestion, heartburn, and GI upset.
Contraindications: Hypersensitivity, renal impairment pregnancy category may use during pregnancy and while
breastfeeding.
Adverse/Side-effects: Abdominal cramps, constipation, fecal impaction, nausea, vomiting
Interactions: May decrease efficacy of most oral medications by inhibiting gastric absorption unless separated by
2 or more hours.
Mission Impact: None
AMOXICILLIN/CLAVULANATE (AUGMENTIN)
Class: Antimicrobial – antibiotic, aminopenicillin β-lactamase inhibitor SECTION 4
Action: Interferes with cell wall replication in certain organisms through osmotic instability and β-lactamase inhibitor
Dose: PO immediate release: 500mg q8–12hr or 875mg bid; PO extended release: 2,000mg bid
Indications: Lower respiratory tract infections, otitis media, sinusitis, skin and skin structure infections, urinary tract
infections, animal bites (dog)
Contraindications: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions can occur in individuals
with history of penicillin hypersensitivity; do not use in patients with a history of liver failure; pregnancy category may
use during pregnancy and while breastfeeding
Adverse/Side-effects: Diarrhea/loose stools, nausea, skin rashes and urticaria, vomiting, vaginitis, hypersensitivity
reactions, hepatic dysfunction, blood and lymphatic dysfunction (likely hypersensitivity-related)
Interactions: May increase effect anticoagulants, decrease effectiveness of oral contraceptives.
Mission Impact: GROUNDING for personnel on flight status
K9 Dosage: 10–20mg/kg PO bid × 5–7 days
ATOVAQUONE-PROGUANIL (MALARONE)
Class: Antimicrobial; antimalarial
Dose: Prophylaxis: 250mg/100mg qd; start 1 to 2 days prior to entering a malaria- endemic area, continue throughout
the stay and for 7 days after returning; Treatment: 1,000mg/400mg qd × 3 days
Indications: Prophylaxis and treatment of Plasmodium falciparum malaria
Contraindications: Hypersensitivity to atovaquone or proguanil, renal impairment, pregnancy category avoid use
during pregnancy and while breastfeeding
Adverse/Side-effects: Headache, abdominal pain, nausea, vomiting, diarrhea, dizziness, cough (pediatrics), liver
transaminase elevations, possible association with seizures and psychotic events (e.g., hallucinations), cutaneous
reactions, including photosensitivity, erythema multiforme and Stevens-Johnson syndrome
Mission Impact: None
2022 RANGER MEDIC HANDBOOK 143

